Greg Wendel's Biography

Greg Wendel, Head, Sample Management Group, Novartis Institutes for BioMedical Research

With 25+ years of innovative scientific instrumentation design involving specifying, designing, building and utilizing automation robots, instruments and systems in the modern drug discovery and Compound Management laboratories , Dr. Wendel applies deep expertise and critical thinking to Sample Management and automation projects.

Automating the Compound Bank – Accelerating Drug Discovery

Friday, 7 June 2013 at 09:00

Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com

As drug discovery timelines become compressed the pressure to accelerate the screening and optimization processes increases. Compound Management must also accelerate to meet the increased demands. This talk will highlight the evolution of the Novartis CM infrastructure and feature the fast and flexible automation that is being brought into the lab and its impact on Discovery.

Add to Calendar ▼2013-06-06 00:00:002013-06-07 00:00:00Europe/LondonEuropean Lab Automation 2013European Lab Automation 2013 in HamburgHamburgSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors